| 000 | 00000nas 2200000za 4500 |
| 001 | 9.507530 |
| 003 | CaOODSP |
| 005 | 20221107133807 |
| 007 | cr ||||||||||| |
| 008 | 150406d20122019oncqr p o||||f0 a0eng|d |
| 022 | |a2561-5572 |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH2-2E-PDF |
| 222 | 0|aDrug submission performance quarterly report ... |b(Canada. Biologics and Genetic Therapies Directorate) |
| 245 | 00|aDrug submission performance quarterly report ... |h[electronic resource] / |cBiologics and Genetic Therapies Directorate. |
| 246 | 37|aBGTD quarterly drug submission performance report |
| 260 | |aOttawa : |bHealth Canada, |c2012-2019. |
| 310 | |aQuarterly |
| 362 | 1 |aBegan with: Jan.-Mar. 2012; suspended with July-Sept. 2012; resumed with Oct.-Dec. 2017; ceased with Oct.-Dec. 2019. |
| 500 | |aIssued also in French under title: Rapport trimestriel du rendement des présentations de drogue... |
| 692 | 07|2gccst|aDrugs |
| 710 | 1 |aCanada. |bHealth Canada. |
| 775 | 08|tRapport trimestriel du rendement des présentations de drogue ... |w(CaOODSP)9.503920 |
| 785 | 00|tDrug submission performance quarterly report / |w(CaOODSP)9.893870 |